These findings indicate that TRAF3IP2-AS1 might act as a tumor suppressor lncRNA in NONO-TFE3 tRCC. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.